Retrionex

A compliance-grade AI platform that turns fragmented pharmaceutical content into validated, traceable scientific intelligence.

case image

AT A GLANCE

Retrionex is a centralized AI knowledge management platform developed for a mid-size US pharmaceutical company. It connects SOPs, scientific publications, medical responses, regulatory materials, and training content into a single secure semantic layer.

The platform supports pharmaceutical knowledge management by allowing users to ask questions in natural language and receive grounded answers based only on approved enterprise content, with explicit references to every source used.

Retrionex reduced the average time required to locate validated information from 18 minutes to 10–11 minutes and accelerated scientific response preparation by up to 35%.

THE CLIENT

The client is a mid-size US pharmaceutical company whose Medical Affairs, Regulatory Affairs, and Scientific Operations teams work with large volumes of scientific, medical, and compliance-sensitive documentation.

These teams prepare medical responses, support regional inquiries, review regulatory materials, train internal stakeholders, and reuse approved content across markets. The company needed medical affairs software that could improve access to validated knowledge without replacing its existing repositories.

As content volumes and regional operations expanded, the organization also required a more consistent approach to scientific knowledge management, source verification, content reuse, and access control.

BUSINESS CHALLENGE

Scientific and regulatory knowledge was distributed across disconnected repositories containing SOPs, publications, medical response documents, regulatory materials, and training content. Medical Affairs and Regulatory teams had to search across several systems, compare document versions, verify approval status, and confirm whether content could be reused for a specific region or audience.

This fragmentation slowed access to validated information, increased manual research effort, and led to inconsistent reuse of approved content across markets. General-purpose AI tools also introduced the risk of generating unsupported responses or using information outside the company’s approved knowledge base.

The company needed secure pharmaceutical AI solutions that could retrieve only validated internal content, preserve source traceability, and enforce role- and region-based access. It also required a partner with relevant expertise in AI development services to integrate semantic retrieval, controlled generation, and enterprise governance into a single system.

SOLUTION SUMMARY

Through a focused pharmaceutical software development engagement, Computools delivered Retrionex as a centralized AI knowledge layer built on top of the client’s existing repositories. Content from SOPs, publications, medical responses, regulatory materials, and training libraries is ingested, normalized, classified, and indexed within a unified semantic environment.

The platform applies RAG for pharmaceutical knowledge and semantic search for pharmaceutical data to retrieve approved documents based on meaning and context rather than exact keywords. Users submit questions in natural language and receive grounded answers with direct references to the source documents used.

By applying AI for medical affairs, Retrionex improves scientific information management while preserving existing repositories and approval processes. Role-based access, audit logging, document-level permissions, and compliance guardrails restrict generation to authorized content and maintain full traceability for every response.

IMPACT

Retrionex delivered measurable improvements across Medical Affairs, Regulatory, and Scientific Operations:

  • approximately 40% faster access to validated information, reducing average search time from 18 minutes to 10–11 minutes;
  • up to 35% faster scientific and medical response preparation, reducing turnaround time from 2.5 days to 1.6–1.8 days;
  • up to 25% greater consistency in approved-content reuse across regions;
  • 100% traceability of generated answers to approved source documents;
  • 0 unauthorized content generation under the platform’s strict grounding rules.

The platform strengthened regulatory knowledge management, reduced the need for repeated source verification, and helped regional teams reuse approved scientific content with greater consistency and control.

WHY COMPUTOOLS

Computools combined enterprise knowledge architecture, AI engineering, semantic search, product design, and compliance-focused delivery into a single implementation model.

The team mapped existing repositories, approval rules, access dependencies, and Medical Affairs workflows before building the ingestion, retrieval, and generation layers. A phased approach with validation checkpoints helped improve search relevance, source grounding, and access controls before broader rollout.

Launch your software solution within 1-3 months instead of years. Unlock tomorrow. Build a future-ready business through innovation.

STORY IN DEPTH

Background

Medical Affairs, Regulatory Affairs, and Scientific Operations teams worked with large volumes of content distributed across SOP libraries, publication databases, approved response documents, training portals, and regional repositories.

The same scientific topic could appear in several files with different versions, approval statuses, geographic limitations, and access permissions. Employees had to search across systems, verify which document was current, and confirm whether it could be reused for a specific market or audience.

This slowed response preparation, increased manual source validation, and made it difficult to maintain consistent use of approved materials across regions.

Approach to solution

Computools built Retrionex as a centralized intelligence layer on top of the client’s existing content repositories. Documents were ingested, normalized, enriched with metadata, and classified by content type, version, region, approval status, and access level before being indexed in a unified semantic environment.

When users submitted questions in natural language, the platform retrieved only relevant approved documents and generated grounded responses with direct source references. Permission rules were applied before retrieval and generation, while unsupported answers were blocked when the system could not find sufficient approved evidence.

This approach created one searchable layer across existing repositories without requiring the client to migrate content or replace established approval workflows.

Integration challenges & approach

The client’s scientific and regulatory content was distributed across multiple repositories with different document formats, metadata structures, versioning models, and update cycles. Building separate point-to-point connections would have increased maintenance effort and made it difficult to keep indexed content up to date.

Computools implemented a shared ingestion and synchronization layer that connected existing repositories, extracted content and metadata, normalized document attributes, and tracked version and approval-status changes. The platform mapped all materials into a unified enterprise schema and updated the semantic index as source documents changed.

This approach gave Retrionex consistent access to current, approved content across connected systems without requiring the client to migrate documents or replace existing repositories.

Computools role

Computools acted as the end-to-end delivery partner, responsible for:

  • Analysis of scientific, regulatory, and content approval workflows;
  • Repository and content-source mapping;
  • Product strategy, UX/UI design, and platform architecture;
  • Enterprise content ingestion and normalization;
  • Semantic retrieval architecture;
  • Retrieval-Augmented Generation orchestration;
  • Enterprise knowledge schema development;
  • Role-based and document-level access control;
  • Compliance guardrails and audit logging;
  • Testing, launch, and ongoing optimization.

The team worked with Medical Affairs, Regulatory Affairs, Scientific Operations, compliance, and IT stakeholders to align the platform with content approval, access, and traceability requirements.

Key decisions and outcomes

Key architectural decisions focused on keeping existing repositories separate from the intelligence layer, restricting response generation to approved enterprise content, and preserving direct source references for every answer.

The platform also used meaning-based retrieval instead of keyword-only search and enforced permissions at both the document and query levels. 

As a result, the average time required to locate validated information fell from 18 to 10–11 minutes, an improvement of approximately 40%. 

Scientific and medical response preparation decreased from 2.5 days to 1.6–1.8 days, reducing turnaround time by approximately 30–35%.

These changes also improved consistency in the reuse of approved content across regions by up to 25% and ensured full traceability of generated answers.

Design

The design focused on fast content discovery, transparent source verification, and clear visibility into document status, regional applicability, and access restrictions.

USER PERSONA → SITE MAP → WIREFRAMES → USER INTERFACE

USER PERSONA

Defining scientific response workflows and compliance requirements to support faster access to validated enterprise content.

SITE MAP

Structuring scientific content, natural-language retrieval, source review, access controls, and audit functions within one platform.

WIREFRAMES

Designing low-fidelity layouts for content retrieval, source-linked responses, document validation, and compliance review.

USER INTERFACE

The interface provides users with immediate access to grounded responses, supporting documents, approval status, regional applicability, and access restrictions on a single review screen.

DIGITAL PLATFORM & TECHNOLOGY

PROJECT MANAGEMENT METHODOLOGY

An Agile approach with Scrum supported iterative development and continuous validation of retrieval quality, source traceability, access controls, and compliance rules.

Work was organized into short sprints with a prioritized backlog, regular stakeholder reviews, and clear checkpoints for ingestion quality, search relevance, grounded generation, and user permissions. This allowed the team to refine the platform before a broader rollout without disrupting existing content management processes.

PROJECT MANAGEMENT METHODOLOGY

PROJECT TIMELINE

image

WHAT OUR CLIENT SAID

Retrionex has simplified how our teams access approved scientific content. Users can ask questions, receive well-supported answers, and instantly access relevant documents, eliminating the need to search multiple repositories and manually verify versions.

The biggest benefit is confidence. Every answer is linked to its sources, and users only see content approved for their region and role. We prepare scientific responses faster and reuse validated materials more consistently across the organization.

CONTACT US TO GET A COST-EFFECTIVE
PROJECT ESTIMATE

Thank you for your message!

Your request will be carefully researched by our experts. We will get in touch with you within one business day.

WHAT HAPPENS NEXT?

01.
We deeply analyse your request.
02.
We create project roadmap, accelerating your time-to-value.
03.
We co-scope features, minimizing project risk upfront.
04.
We submit a comprehensive project proposal with estimates, timelines, CVs, etc.
Trusted by: